HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meilei Ma Selected Research

pranidipine

1/2006Comparative effects of pranidipine with amlodipine in rats with heart failure.
9/2004Effects of pranidipine, a novel calcium channel antagonist, on the progression of left ventricular dysfunction and remodeling in rats with heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meilei Ma Research Topics

Disease

26Myocarditis (Carditis)
04/2012 - 01/2003
25Fibrosis (Cirrhosis)
07/2012 - 01/2003
23Heart Failure
04/2012 - 01/2003
14Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
07/2012 - 01/2003
9Hypertrophy
07/2012 - 09/2004
7Inflammation (Inflammations)
04/2012 - 12/2004
7Left Ventricular Dysfunction
07/2010 - 09/2004
6Cardiomegaly (Heart Hypertrophy)
01/2011 - 02/2005
5Body Weight (Weight, Body)
06/2006 - 12/2003
3Cardiotoxicity
01/2011 - 06/2006
3Diabetic Cardiomyopathies
05/2008 - 06/2005
3Ventricular Remodeling
03/2007 - 02/2005
2Cardiovascular Diseases (Cardiovascular Disease)
07/2012 - 02/2012
2Diabetes Mellitus
01/2011 - 09/2009
2Neoplasms (Cancer)
07/2010 - 06/2006
2Brain Ischemia (Cerebral Ischemia)
03/2007 - 04/2006
2Reperfusion Injury
03/2007 - 04/2006
2Ischemia
03/2007 - 04/2006
2Hyperthyroidism
01/2005 - 08/2003
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Brain Edema (Cerebral Edema)
01/2019
1Kidney Diseases (Kidney Disease)
01/2011
1Myocardial Infarction
07/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2010
1Heart Diseases (Heart Disease)
09/2009
1Proteinuria
08/2009

Drug/Important Bio-Agent (IBA)

12CollagenIBA
02/2012 - 09/2003
10Atrial Natriuretic Factor (ANF)IBA
07/2012 - 01/2003
8Messenger RNA (mRNA)IBA
11/2010 - 01/2003
7Myosins (Myosin)IBA
07/2012 - 10/2007
7Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2010 - 09/2004
6Proteins (Proteins, Gene)FDA Link
07/2010 - 04/2006
5Cardiac MyosinsIBA
07/2012 - 02/2005
5Angiotensin Receptor AntagonistsIBA
06/2011 - 01/2003
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2011 - 01/2003
514-3-3 Proteins (14-3-3 Protein)IBA
01/2011 - 06/2005
4olmesartanIBA
07/2012 - 11/2010
4Telmisartan (Micardis)FDA Link
02/2012 - 07/2010
4CytokinesIBA
06/2011 - 12/2004
4Angiotensin IIIBA
01/2011 - 01/2005
4p38 Mitogen-Activated Protein KinasesIBA
01/2011 - 04/2006
4Carvedilol (Coreg)FDA LinkGeneric
01/2011 - 12/2003
3EdaravoneIBA
01/2019 - 04/2006
3AngiotensinsIBA
04/2012 - 12/2003
3Daunorubicin (Cerubidine)FDA LinkGeneric
01/2011 - 06/2006
3Streptozocin (Streptozotocin)FDA Link
01/2011 - 06/2005
3Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
03/2008 - 02/2008
3Quinapril (Accupril)FDA LinkGeneric
07/2004 - 01/2003
2Angiotensin-Converting Enzyme 2IBA
04/2012 - 01/2011
2Peptides (Polypeptides)IBA
04/2012 - 03/2008
2OsteopontinIBA
03/2012 - 01/2011
2AntioxidantsIBA
03/2012 - 04/2006
2angiotensin I (1-7)IBA
02/2012 - 01/2011
2Pharmaceutical PreparationsIBA
06/2011 - 01/2011
2ChemokinesIBA
06/2011 - 12/2004
2Angiotensin II Type 1 Receptor BlockersIBA
02/2011 - 11/2010
2InterleukinsIBA
01/2011 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 01/2011
2Natriuretic PeptidesIBA
01/2011 - 01/2003
2Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2010 - 01/2003
2AnthracyclinesIBA
07/2010 - 06/2006
2Losartan (Cozaar)FDA LinkGeneric
08/2009 - 04/2006
2Furosemide (Lasix)FDA LinkGeneric
03/2008 - 02/2008
2TolvaptanFDA Link
03/2008 - 11/2007
2DiureticsIBA
03/2008 - 06/2006
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
02/2008 - 02/2008
2Torsemide (Demadex)FDA LinkGeneric
02/2008 - 02/2008
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2007 - 09/2003
2candesartanIBA
06/2006 - 01/2003
2Protein Kinase C betaIBA
04/2006 - 06/2005
2pranidipineIBA
01/2006 - 09/2004
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2006 - 09/2004
2Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2005 - 12/2003
2CalciumIBA
01/2005 - 08/2003
2EnalaprilFDA LinkGeneric
07/2004 - 12/2003
1Matrix Metalloproteinases (MMPs)IBA
07/2012
1Olmesartan Medoxomil (Votum)FDA Link
07/2012
1Vasoconstrictor AgentsIBA
04/2012
1Peptide Hydrolases (Proteases)FDA Link
04/2012
1Glucose (Dextrose)FDA LinkGeneric
03/2012
1Receptor for Advanced Glycation End ProductsIBA
03/2012
1Mitogen-Activated Protein KinasesIBA
03/2012
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
03/2012
1PowdersIBA
03/2012
1Protein Kinases (Protein Kinase)IBA
03/2012
1CurcuminIBA
10/2011
1AutoantibodiesIBA
06/2011
1MAP-kinase-activated kinase 2IBA
01/2011
1Interleukin-6 (Interleukin 6)IBA
01/2011
1Connective Tissue Growth FactorIBA
01/2011
1PPAR gammaIBA
07/2010
1Transforming Growth Factor beta (TGF-beta)IBA
07/2010
1Mitogen-Activated Protein Kinase 14IBA
09/2009
1RNA (Ribonucleic Acid)IBA
05/2009
1Arginine (L-Arginine)FDA Link
05/2009
1Fatty Acids (Saturated Fatty Acids)IBA
05/2009
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2009

Therapy/Procedure

2Therapeutics
04/2012 - 02/2005
2Oral Administration
01/2005 - 01/2003